Combination Therapy in Participants With Active Psoriatic Arthritis Using Subcutaneous Guselkumab and Golimumab: Week 24 Results From a Phase 2a, Multicenter, Randomized, Double-Blind, Proof-of-Concept Study.

2026

https://researcherprofiles.org/profile/774764689

41878957

Scher JU, McInnes IB, Soriano ER, Merola JF, Bird P, Chandran V, Cheng E, Reynoso E, Chen W, Li M, Gensler LS, Mease PJ, Ritchlin CT